MedTrace Logo

The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

NCT04664049 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 51000

Last updated 2021-01-13

No results posted yet for this study

Summary

Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).

Conditions

Interventions

DIETARY_SUPPLEMENT

NRICM101

Direction: Take 1 sachet 2-4 times daily directly or with 400cc water before or between meals Indication: Externally contracted seasonal epidemic Function: Relieving Exterior and Facilitating Lung, clear heat of lung, Wide chest and resolve phlegm

Sponsors & Collaborators

  • National Research Institute of Chinese Medicine, Ministry of Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Yi-Chang Su, MD, PhD · National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-23
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04664049 on ClinicalTrials.gov